MYH6 Variants Are Associated with Atrial Dysfunction in Neonates with Hypoplastic Left Heart Syndrome

Melissa Quintanilla Anfinson1, Sara Creighton2, Pippa M Simpson3

  • 1Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Genes
|November 27, 2024
PubMed

Insights

MYH6 gene variants, a risk factor for hypoplastic left heart syndrome (HLHS), impair right atrial (RA) contractility and function. This RA dysfunction may contribute to RV failure and worse outcomes in HLHS patients with MYH6 variants.

Area of Science:

  • Cardiology
  • Genetics
  • Echocardiography

Background:

  • MYH6 variants are a significant genetic risk factor for hypoplastic left heart syndrome (HLHS), impacting cardiac transplant-free survival.
  • MYH6 encodes alpha-myosin heavy chain (α-MHC), a key contractile protein in neonatal heart atria.

Purpose of the Study:

  • To assess atrial function in HLHS patients carrying MYH6 variants.
  • To investigate the functional consequences of MYH6 variants on cardiac performance in HLHS.

Main Methods:

  • Retrospective, blinded analysis of pre-stage I atrial function using 2D speckle-tracking echocardiography (2D-STE).
  • Measurement of right atrial (RA) and right ventricular (RV) strain and strain rate (SR).
  • Control-matching of variant carriers based on AV valve anatomy, sex, and birth year.

Main Results:

  • HLHS patients with MYH6 variants showed significantly decreased RA active strain (ASct) compared to controls.
  • No significant differences in RV strain were observed between MYH6 variant carriers and controls.
  • RA reservoir (ASr) and conduit strain (AScd) correlated with heart rate (HR) in variant carriers, while RV function correlated with HR in controls.

Conclusions:

  • MYH6 variants are associated with impaired RA contractility, reservoir, and conduit function in HLHS patients.
  • Despite preserved RV function, RA dysfunction and reduced atrial 'kick' may contribute to RV failure and adverse outcomes in these patients.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
4
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K